Scientists Focus On India And China As Source of Zantac Contamination

Offshore drug manufacturing operations in China and India are a likely source of ranitidine Zantac NDMA contamination

Monday, October 26, 2020 - Zantac, the best-selling brand of heartburn and acid reflux medicine in the world, was recently recalled from store shelves having tested for high, carcinogenic levels of N-Nitrosodimethylamine (NDMA). Thousands of individuals have filed suit against its maker Sanofi for failing to warn them of the cancer dangers of taking the drug. Individuals suing Sanofi have developed a long list of types of cancer that included stomach cancer, bladder cancer, prostate, colon, and breast cancer, to name just a few. The Food and Drug Administration (FDA) has been aware of NDMA contamination since Zantac became popular around 30 years ago and set a limit of 96 nonograms per day or Zantac tablet as being an acceptable limit. Researchers testing Zantac found as many as 3 million nanograms per tablet, setting off the current Zantac cancer public health crisis. To date, researchers disagree as to just how Zantac came to be so deadly. Scientists think that NDMA increases when exposed to high temperatures during shipping and storage and that NDMA increases due to interaction with nitrites in processed meats in the stomach. I think a more credible reason for Zantac NDMA contamination could be during the manufacturing process overseas in China. Zantac cancer attorneys are offering a no obligation, free consultation to people suffering from Zantac stomach cancer.

Most cities in India and China are notorious for levels of pollution never before seen. Chinese manufacturing plants are near industrial production facilities of every size and shape. China and India have virtually no rules about industrial pollution of the environment. NDMA in the air, water, and soil around these plants may be responsible for contaminating drug tablet manufacturing. The Center for Disease Control (CDC) confirms the environmental contamination around manufacturing facilities in its description of NDMA. The CDC describes NDMA as: "It is a yellow liquid which has no distinct odor. It is produced in the U.S. only for use as a research chemical. NDMA was used to make rocket fuel, but this use was stopped after unusually high levels of this compound were found in air, water, and soil samples collected near a rocket fuel manufacturing plant." The Hill identifies sources in India as being possible places for ranitidine's NDMA contamination, "This product is manufactured in the United Kingdom and Australia, whereas generic versions of the drug (ranitidine) recently recalled by Glaxo-Smith-Kline, Teva and others were made in India. This issue raises questions about drugs that are made overseas." WTOP adds that in addition to environmental contamination, China and India have relatively ineffective safety standards compared to what the US consumer is accustomed to. "Lax safety standards and FDA oversight at plants in those two countries have allowed these drugs - and likely countless more we don't know about - to become contaminated and endanger patients." China's role in manufacturing ranitidine is much greater than the statistics show because it manufactures many of the components that go into making ranitidine. "China and India now manufacture about 80% of the drugs consumed in the U.S. This figure understates China's dominance because many of the active ingredients in the Indian manufactured drugs come from China," according to WTOP.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.